|
|
|
|
| LEADER |
00000cam a2200000Ia 4500 |
| 001 |
in00002592938 |
| 005 |
20211202193305.0 |
| 006 |
m d f |
| 007 |
cr an||||||||| |
| 008 |
100322s2003 mdu sb f000 0 eng d |
| 035 |
|
|
|a (OCoLC)ocn565949861
|
| 040 |
|
|
|a GPO
|c GPO
|d MvI
|d UtOrBLW
|
| 043 |
|
|
|a n-us---
|
| 049 |
|
|
|a WWW
|
| 074 |
|
|
|a 0499-T (online)
|
| 086 |
0 |
|
|a HE 20.4702:IN 8/4
|
| 245 |
0 |
0 |
|a Guidance for industry :
|b INDs for phase 2 and phase 3 studies, chemistry, manufacturing, and controls information.
|
| 246 |
3 |
0 |
|a INDs for phase 2 and phase 3 studies, chemistry, manufacturing, and controls information
|
| 264 |
|
1 |
|a [Rockville, Md.] :
|b U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research,
|c [2003]
|
| 300 |
|
|
|a 1 electronic resource (24 pages)
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a "CMC."
|
| 500 |
|
|
|a "May 2003."
|
| 504 |
|
|
|a Includes bibliographical references (pages 23-24).
|
| 500 |
|
|
|a Electronic resource.
|
| 650 |
|
0 |
|a Medicine, Experimental
|x Government policy
|z United States.
|
| 650 |
|
0 |
|a Drug approval
|z United States.
|
| 710 |
2 |
|
|a Center for Drug Evaluation and Research (U.S.)
|
| 856 |
4 |
0 |
|u https://purl.fdlp.gov/GPO/LPS120770
|t 0
|
| 999 |
|
|
|a MARS
|
| 999 |
f |
f |
|s 1c747bea-6e28-3e40-8ac2-be7e5a993f45
|i 973d0b61-8b6e-3383-af92-24ce16638966
|t 0
|
| 952 |
f |
f |
|a Texas A&M University
|b College Station
|c Electronic Resources
|d Available Online
|t 0
|e HE 20.4702:IN 8/4
|h Superintendent of Documents classification
|
| 998 |
f |
f |
|a HE 20.4702:IN 8/4
|t 0
|l Available Online
|